Inter-organ metabolic communication involved in energy homeostasis: Potential therapeutic targets for obesity and metabolic syndrome

Pharmacology and Therapeutics

Volumn 117, Issue 1, 2008, Pages 188-198

  Yamada, Tetsuya ^a   Oka, Yoshitomo ^a   Katagiri, Hideki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autonomic nervous system; Central nervous system; Energy homeostasis; Inter organ communication; Metabolic syndrome; Obesity

Indexed keywords

ADIPOCYTOKINE; FATTY ACID; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HUMORAL ANTIBODY; INSULIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ADIPOSE TISSUE; HOMEOSTASIS; HUMAN; METABOLIC SYNDROME X; NERVE FIBER; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ADIPOKINES; AUTONOMIC NERVOUS SYSTEM; BODY WEIGHT; BRAIN; DRUG DELIVERY SYSTEMS; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; METABOLIC SYNDROME X; NEURONS, AFFERENT; OBESITY;

EID: 36549043468     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2007.09.006     Document Type: Review

References (120)

1. Abbott C.R., Monteiro M., Small C.J., Sajedi A., Smith K.L., Parkinson J.R., et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044 1 (2005) 127-131
2. Badman M.K., and Flier J.S. The gut and energy balance: visceral allies in the obesity wars. Science 307 5717 (2005) 1909-1914
3. Bartness T.J., and Bamshad M. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physiol 275 5 Pt 2 (1998) R1399-R1411
4. Bates S.H., and Myers M.G. The role of leptin->STAT3 signaling in neuroendocrine function: an integrative perspective. J Mol Med 82 1 (2004) 12-20
5. Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349 10 (2003) 941-948
6. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418 6898 (2002) 650-654
7. Bence K.K., Delibegovic M., Xue B., Gorgun C.Z., Hotamisligil G.S., Neel B.G., et al. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med 12 8 (2006) 917-924
8. Bernal-Mizrachi C., Xiaozhong L., Yin L., Knutsen R.H., Howard M.J., Arends J.J., et al. An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metab 5 2 (2007) 91-102
9. Bjorbaek C., Elmquist J.K., Frantz J.D., Shoelson S.E., and Flier J.S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1 4 (1998) 619-625
10. Bjorbaek C., Uotani S., da Silva B., and Flier J.S. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 272 51 (1997) 32686-32695
11. Blevins J.E., Stanley B.G., and Reidelberger R.D. Brain regions where cholecystokinin suppresses feeding in rats. Brain Res 860 1-2 (2000) 1-10
12. Boggiano M.M., Chandler P.C., Oswald K.D., Rodgers R.J., Blundell J.E., Ishii Y., et al. PYY3-36 as an anti-obesity drug target. Obes Rev 6 4 (2005) 307-322
13. Brubaker P.L., and Anini Y. Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol 81 11 (2003) 1005-1012
14. Burcelin R., Dolci W., and Thorens B. Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes 49 10 (2000) 1643-1648
15. Burcelin R., Dolci W., and Thorens B. Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 49 10 (2000) 1635-1642
16. Burcelin R., Da Costa A., Drucker D., and Thorens B. Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes 50 8 (2001) 1720-1728
17. Burdakov D., Jensen L.T., Alexopoulos H., Williams R.H., Fearon I.M., O'Kelly I., et al. Tandem-pore K+channels mediate inhibition of orexin neurons by glucose. Neuron 50 5 (2006) 711-722
18. Buscemi S., Verga S., Caimi G., and Cerasola G. Low relative resting metabolic rate and body weight gain in adult Caucasian Italians. Int J Obes (Lond) 29 3 (2005) 287-291
19. Cardin S., Emshwiller M., Jackson P.A., Snead W.L., Hastings J., Edgerton D.S., et al. Portal glucose infusion increases hepatic glycogen deposition in conscious unrestrained rats. J Appl Physiol 87 4 (1999) 1470-1475
20. Chao L., Marcus-Samuels B., Mason M.M., Moitra J., Vinson C., Arioglu E., et al. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106 10 (2000) 1221-1228
21. Cheng A., Uetani N., Simoncic P.D., Chaubey V.P., Lee-Loy A., McGlade C.J., et al. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell 2 4 (2002) 497-503
22. Choi Y.H., Fletcher P.J., and Anderson G.H. Extracellular amino acid profiles in the paraventricular nucleus of the rat hypothalamus are influenced by diet composition. Brain Res 892 2 (2001) 320-328
23. Cota D., Proulx K., Smith K.A., Kozma S.C., Thomas G., Woods S.C., et al. Hypothalamic mTOR signaling regulates food intake. Science 312 5775 (2006) 927-930
24. Crawley J.N., and Beinfeld M.C. Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature 302 5910 (1983) 703-706
25. Cummings D.E. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 89 1 (2006) 71-84
26. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123 4 (2002) 1120-1128
27. DeFronzo R.A., Ratner R.E., Han J., Kim D.D., Fineman M.S., and Baron A.D. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 28 5 (2005) 1092-1100
28. Degen L., Oesch S., Casanova M., Graf S., Ketterer S., Drewe J., et al. Effect of peptide YY3-36 on food intake in humans. Gastroenterology 129 5 (2005) 1430-1436
29. Desvergne B., Michalik L., and Wahli W. Transcriptional regulation of metabolism. Physiol Rev 86 2 (2006) 465-514
30. Donahey J.C., van Dijk G., Woods S.C., and Seeley R.J. Intraventricular GLP-1 reduces short-but not long-term food intake or body weight in lean and obese rats. Brain Res 779 1-2 (1998) 75-83
31. Donovan C.M., Halter J.B., and Bergman R.N. Importance of hepatic glucoreceptors in sympathoadrenal response to hypoglycemia. Diabetes 40 1 (1991) 155-158
32. Drucker D.J. The biology of incretin hormones. Cell Metab 3 3 (2006) 153-165
33. Edwards G.L., Ladenheim E.E., and Ritter R.C. Dorsomedial hindbrain participation in cholecystokinin-induced satiety. Am J Physiol 251 5 Pt 2 (1986) R971-R977
34. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283 5407 (1999) 1544-1548
35. El-Haschimi K., Pierroz D.D., Hileman S.M., Bjorbaek C., and Flier J.S. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105 12 (2000) 1827-1832
36. Eng J., Kleinman W.A., Singh L., Singh G., and Raufman J.P. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 267 11 (1992) 7402-7405
37. Feige J.N., Gelman L., Michalik L., Desvergne B., and Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res 45 2 (2006) 120-159
38. Fishman R.B., and Dark J. Sensory innervation of white adipose tissue. Am J Physiol 253 6 Pt 2 (1987) R942-R944
39. Fliedner S., Schulz C., and Lehnert H. Brain uptake of intranasally applied radioiodinated leptin in Wistar rats. Endocrinology 147 5 (2006) 2088-2094
40. Flier J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116 2 (2004) 337-350
41. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 6704 (1998) 763-770
42. Fujita S., and Donovan C.M. Celiac-superior mesenteric ganglionectomy, but not vagotomy, suppresses the sympathoadrenal response to insulin-induced hypoglycemia. Diabetes 54 11 (2005) 3258-3264
43. Gardemann A., Strulik H., and Jungermann K. A portal-arterial glucose concentration gradient as a signal for an insulin-dependent net glucose uptake in perfused rat liver. FEBS Lett 202 2 (1986) 255-259
44. Giordano A., Song C.K., Bowers R.R., Ehlen J.C., Frontini A., Cinti S., et al. White adipose tissue lacks significant vagal innervation and immunohistochemical evidence of parasympathetic innervation. Am J Physiol Regul Integr Comp Physiol 291 5 (2006) R1243-R1255
45. Gribble F.M., Williams L., Simpson A.K., and Reimann F. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52 5 (2003) 1147-1154
46. Halford J.C. Obesity drugs in clinical development. Curr Opin Investig Drugs 7 4 (2006) 312-318
47. Haynes W.G., Morgan D.A., Walsh S.A., Mark A.L., and Sivitz W.I. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100 2 (1997) 270-278
48. Hevener A.L., Bergman R.N., and Donovan C.M. Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 46 9 (1997) 1521-1525
49. Howard J.K., Cave B.J., Oksanen L.J., Tzameli I., Bjorbaek C., and Flier J.S. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med 10 7 (2004) 734-738
50. Hu Z., Cha S.H., Chohnan S., and Lane M.D. Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proc Natl Acad Sci U S A 100 22 (2003) 12624-12629
51. Imai J., Katagiri H., Yamada T., Ishigaki Y., Ogihara T., Uno K., et al. Cold exposure suppresses serum adiponectin levels through sympathetic nerve activation in mice. Obesity (Silver Spring) 14 7 (2006) 1132-1141
52. Ishigaki Y., Katagiri H., Yamada T., Ogihara T., Imai J., Uno K., et al. Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity. Diabetes 54 2 (2005) 322-332
53. Katagiri H., Yamada T., and Oka Y. Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res 101 1 (2007) 27-39
54. Klaman L.D., Boss O., Peroni O.D., Kim J.K., Martino J.L., Zabolotny J.M., et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20 15 (2000) 5479-5489
55. Koda S., Date Y., Murakami N., Shimbara T., Hanada T., Toshinai K., et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146 5 (2005) 2369-2375
56. Kojima M., and Kangawa K. Ghrelin: structure and function. Physiol Rev 85 2 (2005) 495-522
57. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 6762 (1999) 656-660
58. Kopecky J., Clarke G., Enerback S., Spiegelman B., and Kozak L.P. Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J Clin Invest 96 6 (1995) 2914-2923
59. Kopecky J., Hodny Z., Rossmeisl M., Syrovy I., and Kozak L.P. Reduction of dietary obesity in aP2-Ucp transgenic mice: physiology and adipose tissue distribution. Am J Physiol 270 5 Pt 1 (1996) E768-E775
60. Kopin A.S., Mathes W.F., McBride E.W., Nguyen M., Al-Haider W., Schmitz F., et al. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest 103 3 (1999) 383-391
61. Kreier F., Fliers E., Voshol P.J., Van Eden C.G., Havekes L.M., Kalsbeek A., et al. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat-functional implications. J Clin Invest 110 9 (2002) 1243-1250
62. Kreier F., Kap Y.S., Mettenleiter T.C., van Heijningen C., van der Vliet J., Kalsbeek A., et al. Tracing from fat tissue, liver, and pancreas: a neuroanatomical framework for the role of the brain in type 2 diabetes. Endocrinology 147 3 (2006) 1140-1147
63. Leibel R.L., Rosenbaum M., and Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 332 10 (1995) 621-628
64. Levin B.E., Dunn-Meynell A.A., and Routh V.H. Brain glucose sensing and body energy homeostasis: role in obesity and diabetes. Am J Physiol 276 5 Pt 2 (1999) R1223-R1231
65. Levin B.E., Routh V.H., Kang L., Sanders N.M., and Dunn-Meynell A.A. Neuronal glucosensing: what do we know after 50 years?. Diabetes 53 10 (2004) 2521-2528
66. Luque C.A., and Rey J.A. The discovery and status of sibutramine as an anti-obesity drug. Eur J Pharmacol 440 2-3 (2002) 119-128
67. Matsusue K., Haluzik M., Lambert G., Yim S.H., Gavrilova O., Ward J.M., et al. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111 5 (2003) 737-747
68. Meijer A.J., and Dubbelhuis P.F. Amino acid signalling and the integration of metabolism. Biochem Biophys Res Commun 313 2 (2004) 397-403
69. Miller J.C., Gnaedinger J.M., and Rapoport S.I. Utilization of plasma fatty acid in rat brain: distribution of [14C]palmitate between oxidative and synthetic pathways. J Neurochem 49 5 (1987) 1507-1514
70. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428 6982 (2004) 569-574
71. Moran T.H., Katz L.F., Plata-Salaman C.R., and Schwartz G.J. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am J Physiol 274 3 Pt 2 (1998) R618-R625
72. Mori H., Hanada R., Hanada T., Aki D., Mashima R., Nishinakamura H., et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 10 7 (2004) 739-743
73. Moran T.H., Smedh U., Kinzig K.P., Scott K.A., Knipp S., and Ladenheim E.E. Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 288 2 (2005) R384-R388
74. Munzberg H., Flier J.S., and Bjorbaek C. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145 11 (2004) 4880-4889
75. Muurahainen N., Kissileff H.R., Derogatis A.J., and Pi-Sunyer F.X. Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man. Physiol Behav 44 4-5 (1988) 645-649
76. Niijima A. Afferent signals from leptin sensors in the white adipose tissue of the epididymis, and their reflex effect in the rat. J Auton Nerv Syst 73 1 (1998) 19-25
77. Niswender K.D., Morrison C.D., Clegg D.J., Olson R., Baskin D.G., Myers Jr. M.G., et al. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 52 2 (2003) 227-231
78. Niswender K.D., Morton G.J., Stearns W.H., Rhodes C.J., Myers Jr. M.G., and Schwartz M.W. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413 6858 (2001) 794-795
79. Obici S., Feng Z., Arduini A., Conti R., and Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 9 6 (2003) 756-761
80. Obici S., Feng Z., Morgan K., Stein D., Karkanias G., and Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51 2 (2002) 271-275
81. Orskov C., Wettergren A., and Holst J.J. Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable. Diabetes 42 5 (1993) 658-661
82. Pi-Sunyer X., Kissileff H.R., Thornton J., and Smith G.P. C-terminal octapeptide of cholecystokinin decreases food intake in obese men. Physiol Behav 29 4 (1982) 627-630
83. Plum L., Belgardt B.F., and Bruning J.C. Central insulin action in energy and glucose homeostasis. J Clin Invest 116 7 (2006) 1761-1766
84. Pocai A., Lam T.K., Gutierrez-Juarez R., Obici S., Schwartz G.J., Bryan J., et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434 7036 (2005) 1026-1031
85. Pocai A., Obici S., Schwartz G.J., and Rossetti L. A brain-liver circuit regulates glucose homeostasis. Cell Metab 1 1 (2005) 53-61
86. Poon T., Nelson P., Shen L., Mihm M., Taylor K., Fineman M., et al. Exenatide improves glycemic control and reduces body weight in subjects with type 2 diabetes: a dose-ranging study. Diabetes Technol Ther 7 3 (2005) 467-477
87. Prodi E., and Obici S. Minireview: the brain as a molecular target for diabetic therapy. Endocrinology 147 6 (2006) 2664-2669
88. Proud C.G. Regulation of mammalian translation factors by nutrients. Eur J Biochem 269 22 (2002) 5338-5349
89. Rahimian R., Masih-Khan E., Lo M., van Breemen C., McManus B.M., and Dube G.P. Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol Cell Biochem 224 1-2 (2001) 29-37
90. Rapoport S.I. In vivo labeling of brain phospholipids by long-chain fatty acids: relation to turnover and function. Lipids 31 Suppl (1996) S97-S101
91. Reimann F., and Gribble F.M. Glucose-sensing in glucagon-like peptide-1-secreting cells. Diabetes 51 9 (2002) 2757-2763
92. Rowe I.C., Treherne J.M., and Ashford M.L. Activation by intracellular ATP of a potassium channel in neurones from rat basomedial hypothalamus. J Physiol 490 Pt 1 (1996) 97-113
93. Russek M. Participation of hepatic glucoreceptors in the control of intake of food. Nature 197 (1963) 79-80
94. Russek M. Demonstration of the influence of an hepatic glucosensitive mechanism on food-intake. Physiol Behav 5 10 (1970) 1207-1209
95. Schwartz M.W., Peskind E., Raskind M., Boyko E.J., and Porte Jr. D. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2 5 (1996) 589-593
96. Scott V., Kimura N., Stark J.A., and Luckman S.M. Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour. J Neuroendocrinol 17 7 (2005) 452-457
97. Shi H., and Bartness T.J. White adipose tissue sensory nerve denervation mimics lipectomy-induced compensatory increases in adiposity. Am J Physiol Regul Integr Comp Physiol 289 2 (2005) R514-R520
98. Shimazu T. Central nervous system regulation of liver and adipose tissue metabolism. Diabetologia 20 Suppl (1981) 343-356
99. Smith G.P., Jerome C., Cushin B.J., Eterno R., and Simansky K.J. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 213 4511 (1981) 1036-1037
100. Spanswick D., Smith M.A., Mirshamsi S., Routh V.H., and Ashford M.L. Insulin activates ATP-sensitive K+channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 3 8 (2000) 757-758
101. Stanley S., Wynne K., and Bloom S. Gastrointestinal satiety signals: III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide. Am J Physiol Gastrointest Liver Physiol 286 5 (2004) G693-G697
102. Talsania T., Anini Y., Siu S., Drucker D.J., and Brubaker P.L. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146 9 (2005) 3748-3756
103. Tanida M., Iwashita S., Ootsuka Y., Terui N., and Suzuki M. Leptin injection into white adipose tissue elevates renal sympathetic nerve activity dose-dependently through the afferent nerves pathway in rats. Neurosci Lett 293 2 (2000) 107-110
104. Thorens B., and Larsen P.J. Gut-derived signaling molecules and vagal afferents in the control of glucose and energy homeostasis. Curr Opin Clin Nutr Metab Care 7 4 (2004) 471-478
105. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 6806 (2000) 908-913
106. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M., Meeran K., et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379 6560 (1996) 69-72
107. Uno K., Katagiri H., Yamada T., Ishigaki Y., Ogihara T., Imai J., et al. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312 5780 (2006) 1656-1659
108. Verdich C., Flint A., Gutzwiller J.P., Naslund E., Beglinger C., Hellstrom P.M., et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 86 9 (2001) 4382-4389
109. Wang R., Cruciani-Guglielmacci C., Migrenne S., Magnan C., Cotero V.E., and Routh V.H. Effects of oleic acid on distinct populations of neurons in the hypothalamic arcuate nucleus are dependent on extracellular glucose levels. J Neurophysiol 95 3 (2006) 1491-1498
110. Wang R., Liu X., Hentges S.T., Dunn-Meynell A.A., Levin B.E., Wang W., et al. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 53 8 (2004) 1959-1965
111. West D.B., Fey D., and Woods S.C. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol 246 5 Pt 2 (1984) R776-R787
112. Woods S.C. Gastrointestinal satiety signals: I. An overview of gastrointestinal signals that influence food intake. Am J Physiol Gastrointest Liver Physiol 286 1 (2004) G7-G13
113. Woods S.C., and Gibbs J. The regulation of food intake by peptides. Ann N Y Acad Sci 575 (1989) 236-243
114. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86 12 (2001) 5992
115. Yamada T., and Katagiri H. Avenues of Communication between the Brain and Tissues/Organs Involved in Energy Homeostasis. Endocr J (2007)
116. Yamada T., Katagiri H., Ishigaki Y., Ogihara T., Imai J., Uno K., et al. Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. Cell Metab 3 3 (2006) 223-229
117. Zabolotny J.M., Bence-Hanulec K.K., Stricker-Krongrad A., Haj F., Wang Y., Minokoshi Y., et al. PTP1B regulates leptin signal transduction in vivo. Dev Cell 2 4 (2002) 489-495
118. Zander M., Madsbad S., Madsen J.L., and Holst J.J. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 359 9309 (2002) 824-830
119. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 6505 (1994) 425-432
120. Zorrilla E.P., Iwasaki S., Moss J.A., Chang J., Otsuji J., Inoue K., et al. Vaccination against weight gain. Proc Natl Acad Sci U S A 103 35 (2006) 13226-13231